Advances in Alzheimer’s Disease Research
Potential for Eye Exams to Predict Alzheimer’s
Recent advancements in Alzheimer’s research suggest that it may soon be possible to predict the disease during routine eye examinations. Currently, Alzheimer’s disease impacts approximately 5.4 million individuals in the United States, making it the most prevalent form of dementia. This irreversible and progressive brain disorder affects cognitive functions, memory, and behavior, ultimately rendering even simple tasks challenging for patients. Despite ongoing research, no cure for Alzheimer’s exists, prompting efforts to identify earlier detection methods.
Understanding Preclinical Alzheimer’s Disease
Significant brain damage may occur up to 20 years prior to the manifestation of symptoms. This damage often includes neuronal loss, brain atrophy, and the development of tau tangles and beta-amyloid plaques. Diagnosis typically happens only after these changes are evident, which can lead to substantial damage already having taken place. Research indicates that alterations in the brain occur during the preclinical phase of Alzheimer’s, even when symptoms such as memory loss or behavioral changes are not yet apparent. Current diagnostic methods, including PET scans and spinal taps, are costly, time-consuming, and invasive, highlighting the urgent need for innovative screening techniques.
Link Between Eye Health and Alzheimer’s
Previous studies have identified signs of optic nerve degradation and retinal thinning in individuals who had Alzheimer’s. The central area of the retina, which lacks blood vessels and is crucial for precise vision, has been found to be significantly larger in those with preclinical Alzheimer’s. This implies that eye examinations could play a key role in the early detection of Alzheimer’s before clinical symptoms arise.
Non-Invasive Eye Test for Early Detection
A recent study conducted by researchers at Washington University in St. Louis explored the use of optical coherence tomography angiography to identify eye changes in individuals without visible symptoms of Alzheimer’s. This non-invasive test shines light into the eye, allowing doctors to measure retinal thickness and optic nerve fibers. The angiography technique helps differentiate blood cells from other retinal tissues. The findings were published in JAMA Ophthalmology and involved 30 participants in their mid-70s, all of whom were part of The Memory and Aging Project at Washington University’s Knight Alzheimer’s Disease Research Center.
Study Findings and Implications
Among the participants, none exhibited cognitive normality, yet they lacked clinical symptoms of Alzheimer’s. All underwent eye exams using optical coherence tomography angiography, alongside PET scans and/or spinal taps to identify potential biomarkers indicative of preclinical Alzheimer’s. The results revealed that over half of the participants had elevated levels of beta-amyloid proteins and tau, indicating preclinical Alzheimer’s. These individuals also displayed significant thinning of the central retina, suggesting reduced blood flow to the area. Notably, participants with normal retinal appearances also had normal PET scans and spinal taps.
Future Directions in Alzheimer’s Detection
These findings highlight that retinal changes occur at early stages of preclinical Alzheimer’s, suggesting the potential for eye tests to screen individuals at high risk for the disease. While larger-scale studies are necessary to validate these results, the promise of early detection could allow for timely treatment interventions, potentially delaying further brain damage.
References
O’Bryhim B, RS A, Kung N, Coble D, GP VS. Association of preclinical Alzheimer disease with optical coherence tomographic angiography findings. JAMA Ophthalmol. 2018:1-7. doi:10.1001/jamaophthalmol.2018.3556.
Alzheimer’s one day may be predicted during eye exam. Washington University School of Medicine in St. Louis website https://medicine.wustl.edu/news/alzheimers-one-day-may-be-predicted-during-eye-exam/. Accessed September 8th, 2018.